Vitamin D status in children and young adults with perinatally acquired HIV infection

Clinical Nutrition

Volumn 30, Issue 5, 2011, Pages 624-628

  Rutstein, Richard ^a,b   Downes, Alison ^c   Zemel, Babette ^a,b   Schall, Joan ^a   Stallings, Virginia ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Nutrition; Pediatrics; Perinatally acquired HIV; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MALE; PERINATAL INFECTION; PRESCHOOL CHILD; RACE DIFFERENCE; SPRING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER;

ADOLESCENT; AFRICAN AMERICANS; AGE FACTORS; BODY MASS INDEX; CALCIFEDIOL; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; PHILADELPHIA; PREVALENCE; SEASONS; SEVERITY OF ILLNESS INDEX; URBAN HEALTH; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 80053636597     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.02.005     Document Type: Article

References (30)

1. Wintergerst E.S., Maggini S., Hornig D.H. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007, 51(4):301-323.
2. Holick M.F. The vitamin D epidemic and its health consequences. J Nutr 2005, 135(11):2739S-2748S.
3. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338(12):777-783.
4. Holick M.F., Siris E.S., Binkley N., Beard M.K., Khan A., Katzer J.T., et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90(6):3215-3224.
5. Tangpricha V., Pearce E.N., Chen T.C., Holick M.F. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002, 112(8):659-662.
6. Gordon C.M., DePeter K.C., Feldman H.A., Grace E., Emans S.J. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004, 158(6):531-537.
7. Weng F.L., Shults J., Leonard M.B., Stallings V.A., Zemel B.S. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am J Clin Nutr 2007, 86(1):150-158.
8. Stephensen C.B., Marquis G.S., Kruzich L.A., Douglas S.D., Aldrovandi G.M., Wilson C.M. Vitamin D status in adolescents and young adults with HIV infection. Am J Clin Nutr 2006, 83(5):1135-1141.
9. Kuczmarski R.J., Ogden C.L., Grummer-Strawn L.M., Flegal K.M., Guo S.S., Wei R., et al. CDC Growth Charts: United States. Advance data from vital and health statistics; no. 314 2000, National Center for Health Statistics, Hyattsville, MD, 1-28.
10. Morris N.M., Udry J.R. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980, 9:271-280.
11. Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994, 42:RR-12. Centers for Disease Control.
12. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992, 41:RR-17. Centers for Disease Control.
13. Heaney R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004, 8(6 suppl):1706S-1709S.
14. Bischoff-Ferrari H.A., Giovanucci E., Willett W.C., Dietrich T., Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
15. Hollis B.W. Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Meth Enzymol 1997, 282:174-186.
16. Rovner A.J., Stallings V.A., Schall J.I., Leonard M.B., Zemel B.S. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007, 86:1694-1699.
17. Arpadi S.M., McMahon D., Abrams E.J., Bamji M., Purswani M., Engelson E.S., et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 2009, 123(1):e121-e126.
18. Tebas P., Powderly W.G., Claxton S., Marin D., Tantisiriwat W., Teitelbaum S.L., et al. Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000, 14(4):F63-67.
19. Dolan S.E., Huang J.S., Killilea K.M., Sullivan M.P., Aliabadi N., Grinspoon S. Reduced bone density in HIV-infected women. AIDS 2004, 18(3):475-483.
20. Mora S., Sala N., Bricalli D., Zuin G., Chiumello G., Vigano A. Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy. AIDS 2001, 15(14):1823-1829.
21. Anastos K., Lu D., Shi O., Mulligan K., Tien P.C., Freeman R., et al. The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther 2007, 12(7):1049-1058.
22. Castillo A.B., Tarantal A.F., Watnik M.R., Martin R. Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta). J Orthop Res 2002, 20(6):1185-1189.
23. Giacomet V., Mora S., Martelli L., Merlo M., Sciannamblo M., Vigano A.A. 12-month treatment with tenofovir does not impair bone mineral accrual in HIV-infected children. J Acquir Immune Defic Syndr 2005, 40(4):448-450.
24. Gafni R.I., Hazra R., Reynolds J.C., Maldarelli F., Tullio A.N., DeCarlo E., et al. Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children. Pediatrics 2006, 118(3):e711-e718.
25. Purdy J.B., Gafni R.I., Reynolds J.C., Zeichner R.H. Decreased bone mineral density with off- label use of Tenofovir in children and adolescents infected with human immunodeficiency virus. J Peds 2008 Apr, 152(4):582-584.
26. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
27. Liu P.T., Stenger S., Li H., Tan B.H., Krutzik S.R., Ochoa M.T., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311(5768):1770-1773.
28. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179(4):2060-2063.
29. Stead W.W., Senner J.W., Reddick W.T., Lofgren J.P. Racial differences in susceptibility to infection by Mycobaterium Tuberculosis. N Engl J Med 1990 Feb 7, 322(23):422-427.
30. Clemens T.L., Adams J.S., Henderson S.L., Holick M.F. Increased skin pigment reduces the capacity of skin to synthesize vitamin D3. Lancet 1982 Jan9, 1(8263):74-76.